BiotechTube

Ciprofol + Propofol

ApprovedUNKNOWN
0 views this week 0 watching💤 Quiet
Interest: 39/100
39
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
✓
Phase 3
5
Approved
Indication / Disease

Anesthesia, General

Conditions

Anesthesia, General

Trial Timeline

Sep 3, 2021 → Feb 4, 2022

NCT ID
NCT05035069

About Ciprofol + Propofol

Ciprofol + Propofol is a approved stage product being developed by Haisco Pharmaceutical Group for Anesthesia, General. The current trial status is unknown. This product is registered under clinical trial identifier NCT05035069. Target conditions include Anesthesia, General.

What happened to similar drugs?

1 of 20 similar drugs in Anesthesia, General were approved

Approved (1) Terminated (0) Active (19)
✅Fospropofol disodium, propofol + Fospropofol disodium, propofol + Fospropofol disodium, propofolEisaiApproved
🔄Remimazolam Tosilate + PropofolJiangsu Hengrui MedicinePhase 3
🔄Ropivacaine + BupivacaineAstraZenecaPhase 3
🔄Sugammadex + neostigmineMerckPhase 3
🔄Sugammadex + Rocuronium + Sevoflurane + PropofolMerckPhase 3
🔄Rocuronium + Sugammadex + Neostigmine + AtropineMerckPhase 3
🔄Rocuronium 0.6 mg/kg intubating dose + Rocuronium 0.9 mg/kg intubating dose + Rocuronium 0.1 mg/kg maintenance dose + Rocuronium 0.15 mg/kg maintenance dose + Rocuronium 0.2 mg/kg maintenance + Vecuronium 0.1 mg/kg intubating dose + Vecuronium 0.025 mg/kg maintenance doseMerckPhase 3

Hype Score Breakdown

Clinical
20
Activity
4
Company
15
Novelty
0
Community
0

Clinical Trials (3)

NCT IDPhaseStatus
NCT05035069ApprovedUNKNOWN
NCT04958746Phase 3Completed
NCT04294056Phase 1Completed

Competing Products

20 competing products in Anesthesia, General

See all competitors
ProductCompanyStageHype Score
Fospropofol disodium, propofol + Fospropofol disodium, propofol + Fospropofol disodium, propofolEisaiApproved
43
arm 1 + LUSEDRA + Propofol (arm 3)EisaiPhase 1
29
Remimazolam Tosilate for InjectionJiangsu Hengrui MedicinePre-clinical
26
Remimazolam Tosilate + PropofolJiangsu Hengrui MedicinePhase 3
40
Remimazolam TosylateJiangsu Hengrui MedicinePhase 1
29
HR020602 injection + fentanyl injection ； remifentanil injectionJiangsu Hengrui MedicinePhase 2
35
Remimazolam Tosilate + PropofolJiangsu Hengrui MedicinePhase 2
35
Remimazolam Tosilate + Propofol Injection.Jiangsu Hengrui MedicinePhase 2
35
Ropivacaine + BupivacaineAstraZenecaPhase 3
40
SugammadexMerckPhase 2
35
SugammadexMerckPhase 2
35
Sugammadex + neostigmineMerckPhase 3
40
Sugammadex + Rocuronium + Sevoflurane + PropofolMerckPhase 3
40
Rocuronium + Sugammadex + Neostigmine + AtropineMerckPhase 3
40
Rocuronium 0.6 mg/kg intubating dose + Rocuronium 0.9 mg/kg intubating dose + Rocuronium 0.1 mg/kg maintenance dose + Rocuronium 0.15 mg/kg maintenance dose + Rocuronium 0.2 mg/kg maintenance + Vecuronium 0.1 mg/kg intubating dose + Vecuronium 0.025 mg/kg maintenance doseMerckPhase 3
40
Rocuronium bolus maintenance + rocuronium continuous infusion maintenanceMerckPhase 3
40
Sugammadex + RocuroniumMerckPhase 3
40
Sugammadex + NeostigmineMerckPhase 3
40
sugammadexMerckPhase 3
40
Sugammadex + Succinylcholine + RocuroniumMerckPhase 3
40